Malignant upgrade rate and associated clinicopathologic predictors for concordant intraductal papilloma without atypia: A systematic review and meta-analysis

J Surg Oncol. 2024 May;129(6):1025-1033. doi: 10.1002/jso.27592. Epub 2024 Feb 2.

Abstract

Previously reported upgrade rates for benign breast intraductal papilloma (IDP) are widely variable. However, many previous studies have failed to consider radiologic-pathologic discordance of lesions. This review aims to synthesize malignant upgrade data for benign, concordant IDP at surgical excision. Thirteen studies were included in our meta-analysis. The pooled estimate for percentage underestimation of carcinoma was 1.4% (95% CI: 0.8%-2.0%). We conclude that these lesions can be safely managed by active surveillance.

Keywords: biopsy; breast neoplasms; intraductal; large‐core needle; papilloma.

Publication types

  • Systematic Review
  • Meta-Analysis
  • Review

MeSH terms

  • Breast Neoplasms* / diagnostic imaging
  • Breast Neoplasms* / pathology
  • Breast Neoplasms* / surgery
  • Female
  • Humans
  • Papilloma, Intraductal* / diagnostic imaging
  • Papilloma, Intraductal* / pathology
  • Papilloma, Intraductal* / surgery